Poland· PL-100248620
Aknemycin Plus
A erythromycin, kombinationen product containing erythromycinum + tretinoinum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 6 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Erythromycin, kombinationen is registered in 6 of 19 countries.
Countries holding a registration under ATC D10AF52 (erythromycin, kombinationen), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
Erythromycin, kombinationen · ATC D10AF52
6 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Ireland
- Norwayprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Erythromycinum + Tretinoinum
- Manufacturer
- Delfarma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- D10AF52
- ATC class
- Erythromycin, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909997196367
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Erythromycin, kombinationen in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAknemycin Plus solutionAlmirall Ltd
- CzechiaAKNEMYCIN PLUSAlmirall Hermal GmbH, Reinbek
- GermanyAknemycin PlusAlmirall Hermal Gmbh
- FranceERYLIK, gel pour application cutanéeLABORATOIRES BAILLEUL (LUXEMBOURG)
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Czechia · Aknemycin Plus
- Germany · Aknemycin Plus
- France · Erylik
- United Kingdom (Northern Ireland) · Aknemycin Plus
- Greece · Acmefront, Erytin-Acn
- Slovakia · Aknemycin Plus
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f77d5f5b-5ec4-4cee-b21e-62b1d1b4fc97 GET /v1/drugs/f77d5f5b-5ec4-4cee-b21e-62b1d1b4fc97?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Płyn na skórę",
"source": "urpl",
"strength": "(40 mg + 0,25 mg)/g",
"packaging": "05909997196367 ¦ Rp ¦ 39183\n1 butelka 25 ml",
"substance": "Erythromycinum 40 mg/g + Tretinoinum 0.25 mg/g",
"common_name": "Erythromycinum + Tretinoinum",
"pl_product_id": "100248620",
"pozwolenie_nr": "86/11",
"auth_procedure": "IR",
"authorisation_validity": "2031-04-20"
}See everything about erythromycin, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.